Patents by Inventor Liam Sweeney

Liam Sweeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260232877
    Abstract: The present invention relates to a functionalized metallic implant comprising a metallic substrate having a covalently bound organic acid layer and a polymeric coating covalently attached thereto. The polymeric coating includes cationic, anionic, zwitterionic, and/or hydrophobic functional groups configured to associate therapeutic agents via electrostatic and/or hydrophobic interactions. Therapeutic agent release or availability is controlled as a function of surface charge, hydrophobicity, or both, enabling localized and sustained delivery in response to local biological conditions. In certain embodiments, the coating provides antibacterial activity through contact-based membrane disruption or inhibition of bacterial adhesion. In further embodiments, zwitterionic coatings exhibit pH-responsive charge behavior enabling selective loading and release of therapeutic agents.
    Type: Application
    Filed: February 12, 2026
    Publication date: August 13, 2026
    Applicant: Onkos Surgical, Inc.
    Inventors: Patrick Treacy, Liam Sweeney, Arley Perez, III, Gene Kulesha, Ryan J. Hue
  • Publication number: 20250228949
    Abstract: Collagen matrices of varying charge and cross-linking density are disclosed, and methods for preparing such collagen matrices. The cross-linking methods for collagen impart charge and allow for variable cross-linking density within the collagen device. Such variable cross-linking density imparts variable collagen resorption time, and the variable charge allows sequestering and then releasing therapeutics in a controlled manner. The techniques may be used to impact in vitro mineralization via the charged collagen platform by its interaction with rhBMP-2. The techniques can be used to create a positively charged collagen skin substitute that resists infection and supports wound closure.
    Type: Application
    Filed: January 10, 2025
    Publication date: July 17, 2025
    Inventors: Steven L. Bennett, Liam Sweeney, Bryan Vayda